OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
World game at war: why some European nations have threatened a World Cup boycott 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
ACTON, Mass., May 08, 2018 -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair analysis drug testing, today announced that James Abely has been promoted to the position of Vice President and General Counsel.
In this important role, Jim is responsible for directing and managing all of the company's legal activities, including working closely with the company's clients, and reports directly to the company's CEO. Jim joined Psychemedics in June 2016 as Associate General Counsel, after practicing law for 6 years with the Boston firm of Goodwin Procter LLP, following his graduation from the University of Virginia School of Law. Jim was later promoted to General Counsel.
In making the announcement, Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated "Jim has been an outstanding addition to our team at Psychemedics. In heading up this important area in our company for the past two years, Jim has worked diligently in numerous legal matters and has clearly demonstrated his ability and strong work ethic. He has won the complete confidence of the other members of our management team, as well as our clients. Besides providing our clients with the most vigorous drug test available and outstanding client service, we also extensively support our clients on any legal challenge. We not only provide a litigation packet and expert testimony, but also legal assistance for our clients' legal team to come up to speed quickly. That's why this is such an important role in our company."
Contact:
Raymond C. Kubacki
Chairman, President & CEO
(978) 206-8220
[email protected]
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.
The Psychemedics web site is www.psychemedics.com
